ScholarIQanswers from OpenAlex & ORCID
Jeffrey I. Weitz
ResearcherPublications, citations & collaboration network
Jeffrey I. Weitz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jeffrey I. Weitz have?
ScholarIQindexed works
Jeffrey I. Weitz has 767 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jeffrey I. Weitz have?
ScholarIQcitation count
Jeffrey I. Weitz has 75,436 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jeffrey I. Weitz?
ScholarIQh-index
Jeffrey I. Weitz has an h-index of 119 in OpenAlex.
What is the i10-index of Jeffrey I. Weitz?
ScholarIQi10-index
Jeffrey I. Weitz has an i10-index of 488 in OpenAlex.
What is the ORCID of Jeffrey I. Weitz?
ScholarIQorcid
The ORCID for Jeffrey I. Weitz is on the source record.
What is the OpenAlex record for Jeffrey I. Weitz?
ScholarIQopenalex
The OpenAlex for Jeffrey I. Weitz is on the source record.
What are the most-cited papers on Jeffrey I. Weitz?
ScholarIQmost cited works
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott, Jonathan L. Halperin, Albert L. Waldo, Michael Ezekowitz, Jeffrey I. Weitz, Jindřich Špinar, Witold Rużyłło, Mikhail Ruda, Yukihiro Koretsune, Joshua Betcher, Minggao Shi, Laura T. Grip, Shirali P. Patel, Indravadan Patel, James Hanyok, Michele Mercuri, Elliott M. Antman
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald, Elaine Hoffman, Naveen Deenadayalu, Michael D. Ezekowitz, A. John Camm, Jeffrey I. Weitz, Basil S. Lewis, Alexander Parkhomenko, Takeshi Yamashita, Elliott M. Antman
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Behnood Bikdeli, Mahesh V. Madhavan, David Jiménez, Taylor Chuich, Isaac Dreyfus, Elissa Driggin, Caroline Der‐Nigoghossian, Walter Ageno, Mohammad Madjid, Yutao Guo, Liang Tang, Yu Hu, Jay Giri, Mary Cushman, I. Quéré, Evangelos Dimakakos, C. Michael Gibson, Giuseppe Lippi, Emmanuel J. Favaloro, Jawed Fareed, Joseph A. Caprini, Alfonso Tafur, John Burton, Dominic P. Francese, Elizabeth Wang, Anna Falanga, Claire McLintock, Beverley J. Hunt, Alex C. Spyropoulos, Geoffrey D. Barnes, John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Gregory Y.H. Lip
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel, Peter Verhamme, Tatjana Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Hæusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Rónán Collins, A. John Camm, Hein Heidbüchel, ESC Scientific Document Group, Gregory Y.H. Lip, Jeffrey I. Weitz, Laurent Fauchier, Deirdre A. Lane, Giuseppe Boriani, Andreas Goette, Roberto Keegan, Robert J. MacFadyen, Chern‐En Chiang, Boyoung Joung, Wataru Shimizu
Idarucizumab for Dabigatran Reversal
Charles V. Pollack, Paul A. Reilly, John W. Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, CW Kam, Jeffrey I. Weitz